Latest Medical News Articles | Research Studies in Medicine

Latest News

FDA Approves New Valsartan Product Following Major Recall

The Food and Drug Administration (FDA) has approved a new generic version of Diovan (Novartis) that does not contain N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), 2 potentially carcinogenic impurities identified in several recalled valsartan products.
Next post in News